Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02710097

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II

Status
Active Not Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Yale University · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.

Detailed description

To study the effects of oral ethanol (target BAC of \~0.04g/dl; equivalent to consuming approximately 2 drinks over 1 hour) and vaporized cannabis (\~450 mg cannabis plant material at a THC concentration of \~1.7%; roughly equivalent to smoking approximately 1/4 of a marijuana cigarette, or "joint") on driving.

Conditions

Interventions

TypeNameDescription
DRUGActive inhaled cannabis\~450 mg of active cannabis, which is roughly equivalent to smoking 1/4 of a marijuana cigarette, or "joint". Administered over 20 minutes via a vaporizer.
DRUGPlaceboApproximately 4 drinks of orange juice or ginger ale covered with a trace amount of ethanol on the surface, each administered over approximately 10 minutes.
DRUGActive Oral Ethanol0.4 g/kg ethanol in orange juice or ginger ale to reach a target BrAC of approximately 0.04%. This dose is equivalent to approximately 2 standard drinks over 1 hour. Approximately 4 drinks, each administered over approximately 10 minutes.
DRUGPlaceboNo active cannabinoids. Administered over 20 minutes via a vaporizer.

Timeline

Start date
2016-03-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2016-03-16
Last updated
2025-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02710097. Inclusion in this directory is not an endorsement.